Angany Inc.. has revealed that it has obtained approval from MHRA to carry out the initial clinical trial of its vaccine candidate ANG-101 aimed at combating allergies in humans to cats.
This article summarized the latest R&D progress of lusutrombopag, the Mechanism of Action for lusutrombopag, and the drug target R&D trends for lusutrombopag.
In the wake of the receding tide of COVID-19 oral medication and vaccines, Pfizer seems to have returned to an awkward predicament where all potential growth points have fallen flat.
This article summarized the latest R&D progress of methscopolamine bromide, the Mechanism of Action for methscopolamine bromide, and the drug target R&D trends for methscopolamine bromide.
This article summarized the latest R&D progress of methsuximide, the Mechanism of Action for methsuximide, and the drug target R&D trends for methsuximide.
Despite Novartis being a consistent top contender in the pharmaceutical sector in terms of revenue, its growth and market value in recent years has been rather dismal.
Androgen receptor (AR) is a type of nuclear receptor that is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone in the cytoplasm and then translocating into the nucleus.